Effect of DNA Methylation in Various Diseases and the Probable Protective Role of Nutrition: A Mini-Review (2024)

DNA methyltransferase (DMTF)

DNA methyltransferase (DMTF) is an enzyme involved in methylating cytosine/adenine residues of DNA. There are two types of DMTF: the maintenance DMTF and the denovo DMTF [3]. Maintenance DMTF helps in copying methylated patterns of parent strands to the daughter strand during the replication process. De novo DMTF helps in creating new methylated patterns to DNA during development [4]. In stem cells, the non-methylated regions of DNA are lost during cell differentiation and are a specific feature of stem cells when compared with fibroblasts. Aberrant DNA methylation might contribute to decreased transcriptional activity of some genes involved in stem cell maintenance and differentiation. Thus, methylated/non-methylated DNA pattern transmission depends completely on their location within the gene [5].

Effects of DNA methylation

DNA methylation is an epigenetic modification, i.e., heritable change in DNA without any modifications to the sequence of DNA. It alters expression of a gene during cell differentiation and causes a change that is heritable. Methylated modifications of DNA occur during the mitotic or meiotic division of the cell [6]. Methylated DNA usually represses transcription of a gene and these methylated DNA are not recognized by RNA polymerases; thus, it becomes one of the mechanisms to control gene expression [7]. DNA methylation in turn regulates the expression of enzymes, like histone deacetylase, resulting in the modification of chromatin structure [8].

DNA methylation changes are associated with a number of diseases such as imprinting disorders [9], cardiovascular diseases [10], autoimmune diseases, neurological disorders [11], and cancer [12]. The advantages of DNA methylation in humans include regulation of long-term storage of memory, which can be used to estimate age, and biological clocks in humans [13-15]. DNA can be demethylated by the base-excision repair system.

Cancer

In general, altered DNA methylation is an important factor associated with cancer development. Hypermethylation in an abnormal state leads to transcriptional silencing and gene inactivation, whereas hypomethylation is linked to chromosomal instability and loss of imprinting (transfer of methylated patterns to daughter cells). Thus, DNA methylation can cause hypermethylation of tumor suppressor genes (oncogene suppressor) and hypomethylation of oncogenes [16-17].

Imprinting disorders

The process of expressing the DNA methylation pattern of a specific gene based on parental origin is known as imprinting [18]. The failure of this process of imprinting leads to imprinting disorders. Angelman’s syndrome is an imprinted neurodevelopmental disorder caused due to the deficiency of maternal ubiquitin ligase enzyme. Prader–Willi syndrome is also an imprinting neurobehavourial disorder due to the deficiency of ubiquitin ligase enzyme of paternal origin. Thus, loss of the maternal/paternal imprinting centre leads to abnormal DNA methylations, which could lead to epigenetic modification in DNA [19-20]. Loss of imprinting not only in DNA methylation but also in the binding protein involved in methylation also contributes to imprinting disorders.

Aging

DNA methylation is suppressed during zygote formation and enhanced methylation is seen during development. There is a loss of DNA methylation during aging [21]. Biological clocks act as biomarkers for predicting the process of aging [22]. With the advancement in age, the genes, such as estrogen receptor, insulin–like growth factor 2 (IGF2), p¹⁶, etc., get hypermethylated, and there is abnormal DNA methylation leading to a heritable change.

Atherosclerosis

DNA methylation polymorphism forms an important biomarker for atherosclerosis. Monocytes and lymphocytes are the sites for DNA methylation polymorphism [23-25] (Figure ​(Figure22).

Thus, either hypo- or hypermethylation leads to altered smooth muscle cell proliferation contributing to atherosclerotic lesions. Hypomethylation of monocytes and lymphocytes and hypermethylation of gene-specific areas takes place. Atherosclerosis, if untreated, leads to cardiovascular disease.

Nutrition: Its role in DNA methylation

Nutrition plays an important role in health, diseaseconditions, and influences in utero development. There are areas on DNA, which are sensitive to methylation based on few previous studies on nutrition, and these regions are identified as methylation variable positions (MVP). The observationof MVPs explains the role of nutrition in the fetal origin of adult diseases. There are several theories put forward to explain the fetal origin of adult diseases. These theories describe that nutrition plays an important role on adult disease risk and its transfer to theoffspring [26]. It also predicts that fetal growth impairment is associated with adult cardiovascular disease, diabetes, and insulin resistance [27-28]. A previous study has revealed that prenatal and early post-natal exposure to famine may increase the risk of obesity [29], schizophrenia, lung diseases, and even breast cancer in women [30].

But in humans, folic acidand methionine playan important role in DNA modifications. As we know that folic acid functions as a one-carbon metabolism that supplies carbon for purine and pyrimidine synthesis, it becomes important to have a good understanding of its role in DNA modifications both in utero and in adults.Periconceptional supplementation of folic acid increased DNA methylation by 4.5% of IGF2 [31]. Along with methyl supplementation, the folic acid requirement is very much necessary for postmenopausal women not only for proper nervous system functions but also for preventing epigenetic alterations [32]. In a study, cord blood sample analysis revealed that folic acid status is inversely related to hom*ocysteine and vice-versa [33]. DNA methylation of 12 genes (EIF2C3, ZBTB11, BDH2, ZNF187, RUNX1T1, C9 or f64, PDE2A, MGC33486, AMN, ZPBP2, FBN3, and PVRL2) directly correlated to hom*ocysteine levels and methylation of five genes (ATP5F1, CYP26C1, FSTL3, MDS032, and BMX) showed an inverse correlation with hom*ocysteine levels [34]. Thus, nutrient-based DNA methylation is gene specific, site specific, tissue specific, and age specific.

The authors have declared that no competing interests exist.

1. DNA methylation and autoimmune disease. Richardson B. Clin Imunol. 2003;109:72–79. [PubMed] [Google Scholar]

2. Cytosine DNA methylation is found in Drosophila melanogaster but absent in Saccharomyces cerevisiae, Schizosaccharomyces pombe and other yeast species. Analytical chemistry. Capuano F, Mulleder M, Kok RM, Blom HJ, Ralser M. Anal Chem. 2014;86:3697–3702. [PMC free article] [PubMed] [Google Scholar]

4. Methylation of tRNAAsp by the DNA methyltransferase hom*olog Dnmt2. Goll MG, Kirpekar F, Maggert KA, Yoder JA, Hsieh CL, Zhang X, Golic KG, Jacobsen SE, Bestor TH. Science. 2006;311:395–398. [PubMed] [Google Scholar]

5. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Gonzalgo ML, Liang G, Spruck CH 3rd, Zingg JM, Rideout WM 3rd, Jones PA. Cancer Res. 1997;57:594–599. [PubMed] [Google Scholar]

6. Human DNA methylomes at base resolution show widespread epigenomic differences. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR. Nature. 2009;462:315–322. [PMC free article] [PubMed] [Google Scholar]

7. Genomic DNA methylation: the mark and its mediators. Klose RJ, Bird AP. Trends Biochem Sci. 2006;31:89–97. [PubMed] [Google Scholar]

8. Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated. Choy MK, Movassagh M, Goh HG, Bennett MR, Down TA, Foo RS. BMC Genomics. 2010;11:519. [PMC free article] [PubMed] [Google Scholar]

9. DNA methylation in genomic imprinting, development, and disease. Paulsen M, Ferguson-Smith AC. J Pathol. 2001;195:97–110. [PubMed] [Google Scholar]

10. DNA methylation as a biomarker for cardiovascular disease risk. Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. PLoS One. 2010;5:0. [PMC free article] [PubMed] [Google Scholar]

11. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Urdinguio RG, Sanchez-Mut JV, Esteller M. Lancet Neurol. 2009;8:1056–1072. [PubMed] [Google Scholar]

12. Aberrant DNA methylation as a cancer-inducing mechanism. Esteller M. Annu Rev Pharmacol Toxicol. 2005;45:629–656. [PubMed] [Google Scholar]

13. Covalent modification of DNA regulates memory formation. Miller CA, Sweatt JD. Neuron. 2007;53:857–869. [PubMed] [Google Scholar]

16. Physical activity and global genomic DNA methylation in a cancer-free population. Zhang FF, Cardarelli R, Carroll J, Zhang S, Fulda KG, Gonzalez K, Vishwanatha JK, Morabia A, Santella RM. Epigenetics. 2011;6:293–299. [PMC free article] [PubMed] [Google Scholar]

17. DNA methylation and cancer. Kulis M, Esteller M. Adv Genet. 2011;70:27–56. [PubMed] [Google Scholar]

18. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, Li E, Sasaki H. Nature. 2004;429:900–903. [PubMed] [Google Scholar]

19. Quantitative analysis of SNRPN(correction of SRNPN) gene methylation by pyrosequencing as a diagnostic test for Prader-Willi syndrome and Angelman syndrome. White HE, Durston VJ, Harvey JF, Cross NC. Clin Chem. 2006;52:1005–1013. [PubMed] [Google Scholar]

20. Mechanisms of imprinting of the Prader-Willi/Angelman region. Horsthemke B, Wagstaff J. Am J Med Genet A. 2008;146A:2041–2052. [PubMed] [Google Scholar]

23. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. Lund G, Andersson L, Lauria M, Lindholm M, Fraga MF, Villar-Garea A, Ballestar E, Esteller M, Zaina S. J Biol Chem. 2004;279:29147–29154. [PubMed] [Google Scholar]

24. Increased hom*ocysteine and S-adenosylhom*ocysteine concentrations and DNA hypomethylation in vascular disease. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME, Blom HJ, Jakobs C, Tavares de Almeida I. Clin Chem. 2003;49:1292–1296. [PubMed] [Google Scholar]

25. Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with hom*ocysteine. Huang YS, Zhi YF, Wang SR. Pathophysiology. 2009;16:259–265. [PubMed] [Google Scholar]

27. Fetal nutrition and cardiovascular disease in later life. Barker DJ. Br Med Bull. 1997;53:96–108. [PubMed] [Google Scholar]

28. The fetal origins of type 2 diabetes mellitus. Barker DJ. Ann Intern Med. 1999;130:322–324. [PubMed] [Google Scholar]

29. Obesity in young men after famine exposure in utero and early infancy. Ravelli GP, Stein ZA, Susser MW. NEJM. 1976;295:349–353. [PubMed] [Google Scholar]

30. The Dutch famine and its long-term consequences for adult health. Roseboom T, de Rooij S, Painter R. Early Hum Dev. 2006;82:485–491. [PubMed] [Google Scholar]

31. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, Lindemans J, Siebel C, Steegers EA, Slagboom PE, Heijmans BT. PLoS One. 2009;4:0. [PMC free article] [PubMed] [Google Scholar]

32. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Am J Clin Nutr. 2000;72:998–1003. [PubMed] [Google Scholar]

33. Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma hom*ocysteine and birth weight in humans. Fryer AA, Emes RD, Ismail KM, Haworth KE, Mein C, Carroll WD, Farrell WE. Epigenetics. 2011;6:86–94. [PMC free article] [PubMed] [Google Scholar]

34. CpG islands and the regulation of transcription. Deaton AM, Bird A. Genes Dev. 2011;25:1010–1022. [PMC free article] [PubMed] [Google Scholar]